Upload Avatar (500 x 500)
Changyou Zhan
cyzhan@fudan.edu.cn
Chinese, English
Shanghai
Fudan University
Basic Medical Sciences
  • 2007.09—2010.06 Ph.D. in Pharmaceutics: Fudan University
  • 2005.09—2007.06 Master's in Chemical Engineering: Wuhan University of Technology
  • 2001.09—2005.06 Bachelor's in Pharmaceutical Engineering: Wuhan University of Technology
  • 2015.12—Present - Fudan University - Professor
  • 2012.08—2015.12 - Harvard Medical School/MIT - Postdoctoral Researcher
  • 2010.08—2012.08 - University of Maryland School of Medicine - Postdoctoral Researcher
  • 2019: Shanghai 'Youth Science and Technology Innovation' Mayor Award (Nomination)
  • 2019: Chinese Pharmaceutical Association - Yiling Biomedical Youth Award
  • 2018: Daiichi Sankyo Teaching Fund
  • 2017: Ministry of Education Natural Science Award (Second Prize)
  • 2016: Shanghai Natural Science Award (Second Prize)
  • 2014: Chinese Pharmaceutical Association Science and Technology Award (Second Prize)
  • 2013: American Association of Pharmaceutical Scientists (AAPS) Outstanding Postdoctoral Award
  • 2012: National Excellent Doctoral Dissertation Award
Research on the in vivo process, regulatory mechanisms, and clinical precision medication of lipid nanomedicines
Discovery and efficient delivery of biopharmaceuticals
  • Facile Separation of PEGylated Liposomes Enabled by Anti-PEG scFv, Tang W, Zhang Z, Li C, Chu Y, Qian J, Ying T, Lu W, Zhan C, 2021
  • Self-adjuvant Effect by Manipulating Bio-nano Interface of Liposome-based Nanovaccines, Jiang Z, Liu J, Guan J, Wang H, Ding T, Qian J, Zhan C, 2021
  • Interrogating preclinical study of liposomes: The effect of mouse strain reexamined, Guan J, Wu E, Jin P, Hou S, Qian J, Lu W, Yu B, Zhan C, 2021
  • Regulation of in vivo delivery of nanomedicines by herbal medicines, Guan J, Chen W, Yang M, Wu E, Qian J, Zhan C, 2021
  • Deciphering protein corona by scFv-based affinity chromatography, Chu Y, Tang W, Zhang Z, Li C, Qian J, Wei X, Ying T, Lu W, Zhan C, 2021
  • Anti-PEG scFv corona ameliorates accelerated blood clearance phenomenon of PEGylated nanomedicines, Zhang Z, Chu Y, Li C, Tang W, Qian J, Wei X, Lu W, Ying T, Zhan C, 2021
  • Interrogation of Folic Acid-Functionalized Nanomedicines: The Regulatory Roles of Plasma Proteins Reexamined, Wang H, Ding T, Guan J, Liu X, Wang J, Jin PP, Hou S, Lu W, Qian J, Wang W, Zhan C, 2020
  • Natural IgM dominates in vivo performance of liposomes, Ding T, Guan J, Long Q, Liu X, Qian J, Wei X, Lu W, Zhan C, 2020
  • Brain-targeted drug delivery by manipulating protein corona functions, Zhang Z, Guan J, Jiang Z, Yang Y, Liu J, Hua W, Mao Y, Li C, Lu W, Qian J, Zhan C, 2019
  • Enhanced Immunocompatibility of Ligand-targeted Liposomes by Attenuating Natural IgM Absorption, Guan J, Shen Q, Zhang Z, Jiang Z, Yang Y, Lou M, Qian J, Lu W, Zhan C, 2018
Lipid Nanomedicines In Vivo Process Regulatory Mechanisms Clinical Precision Medication Biopharmaceuticals Efficient Delivery Nanomedicine Liposomes Drug Delivery Protein Corona

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.